BioSpace News Archive

oday the U.S. Food and Drug Administration permitted marketing of a new diagnostic test to aid in detecting a type of herpes virus called cytomegalovirus (CMV) in newborns less than 21 days of age.

Move supports company’s multi-year strategic growth initiative.

Following a successful investigation, Health Canada is reminding Canadians about the dangers of consuming products containing sodium chlorite.

Hikma Pharmaceuticals USA Inc., a wholly owned subsidiary of Hikma Pharmaceuticals PLC (“Hikma”) (LSE:HIK) (NASDAQ Dubai:HIK) (OTC:HKMPY), the multinational generic pharmaceutical company, will demonstrate its commitment to serving the needs of US pharmacists and to patient safety at the upcoming American Society of Health-System Pharmacists’ (ASHP) Midyear Clinical Meeting and Exhibition on December 2-6, 2018 in Anaheim, CA.

Orexo AB today announces that the US Court of Appeals for the Federal Circuit has denied Actavis Elizabeth LLC’s (Actavis) combined petition for panel rehearing and rehearing en banc in the case regarding Orexo’s Zubsolv US patent 8,940,330.

As Mo Bros across Canada prepare to farewell their moustaches on November 30, the Movember Foundation is urging them to shave-down to a ‘Half-Mast Mo’ in one final fundraising act for men’s health.

LabCorp® today updated its full-year 2018 guidance based on current expectations. In the following guidance, all comparisons to financial results in 2017 have been restated as if the Company had adopted the FASB-issued converged standard on revenue recognition (ASC 606) on January 1, 2017.

Revenues for the Nine Months Ended September 30, 2018 Were $3.5 Million Compared to $0.7 Million for the Same Period in 2017

Further Regulatory Submissions Ongoing with Authorities Worldwide

Heska Corporation (NASDAQ: HSKA - News; “Heska” or the “Company”), a provider of advanced veterinary diagnostic and specialty products, today announced that its Heska Imaging, LLC (“Heska Imaging”) subsidiary reached agreement with Cuattro, LLC (“Cuattro”) to purchase certain software and related assets (the “Software”) and to terminate the related license and supply agreements between Heska Imaging and Cuattro (collectively, the “Transactions”).